Immuneering CorporationIMRXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank83
3Y CAGR+39.6%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+39.6%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$3.35M+10.4%
2024$3.03M-38.6%
2023$4.94M+301.4%
2022$1.23M+2773.5%
2021$42834.00+202.7%
2020$-41702.00+97.1%
2019$-1.42M-